Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Exercise circuit shows promise for lung recovery

NCT ID NCT05395390

First seen Jun 24, 2026 · Last updated Jun 24, 2026

Summary

This study tested a hybrid home and on-site resistance training program in 72 adults with COPD, obstructive sleep apnea, or lingering COVID-19 symptoms. Participants completed 18 exercise sessions, 12 on-site, to see if the program could improve muscle loss and fatigue. The goal was to understand how the body responds to this type of training in people with and without chronic respiratory disease.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COVID19 are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Texas A&M University

    College Station, Texas, 77843, United States

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Resistance training (exercise program)

What this could lead to

If successful, this could point toward a practical exercise plan to reduce muscle loss and fatigue in people with chronic lung conditions or after COVID-19.

What could go wrong

This is a small, completed study (72 people) that measured body responses, not long-term health outcomes. Results may not apply to everyone, and exercise programs require consistent effort.

Conditions

The condition(s) this trial relates to.

chronic obstructive pulmonary disease COPD, severe early onset COVID-19 long COVID-19 obstructive sleep apnea syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.